Malignus pajzsmirigytumorok Magyarországon: morbiditás és mortalitás.

Translated title of the contribution: Malignant thyroid tumors in Hungary: morbidity and mortality

O. Ésik, Z. Szentirmay, G. Tusnády, G. Németh, M. Kásler

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In 1993, 181 new cases (36 men and 145 women) of thyroid cancer were diagnosed pathologically in Hungary, i.e. a morbidity of 1.8/100,000 for the total population, and of 0.7/100,000 and 2.7/100,000 for men and women, respectively. The distribution of the histological diagnoses: 61% papillary, 25% follicular, 5% medullary and 3% anaplastic carcinomas, and 6% others. In the same year, 125 patients (31 men and 94 women) died from thyroid cancer, i.e. a mortality rate of 1.2/100,000 for the total population, and of 0.6/100,000 and 1.8/100,000 for men and women, respectively. The relatively low morbidity reflects the fact that no new strong aetiological factor is operative in Hungary. The substantial mortality rate, however, is influenced by the geographically determined aggressivity of the disease, the inadequacy of the diagnostic procedures and therapeutic measures, and lack of the active follow-up. The latter facts are especially prominent in centres with a low patient turnover. In the field of health care, various measures must be introduced to prevent an increase in the morbidity and to diminish the mortality. Reduction of the iodine deficiency, rationalization of the medical use of ionizing irradiation, and implementation of the necessary hormonal medication for all patients operated by resection for thyroid diseases are needed for tumour prophylaxis. Before any medical decision-making, the achievement of complete diagnostic information, including the pathological revision of clinically questionable cases, is of paramount importance. The fundamental goals as concerns the treatment modalities are as follows: increased surgical skill and level of performance of external irradiation, the availability of radionuclide therapy, and guidance of all types of thyroxine medication by endocrine experts.

Original languageHungarian
Pages (from-to)905-911
Number of pages7
JournalOrvosi Hetilap
Volume137
Issue number17
Publication statusPublished - Apr 28 1996

Fingerprint

Hungary
Thyroid Gland
Morbidity
Mortality
Thyroid Neoplasms
Neoplasms
Thyroid Diseases
Thyroxine
Radioisotopes
Iodine
Population
Therapeutics
Carcinoma
Delivery of Health Care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Malignus pajzsmirigytumorok Magyarországon : morbiditás és mortalitás. / Ésik, O.; Szentirmay, Z.; Tusnády, G.; Németh, G.; Kásler, M.

In: Orvosi Hetilap, Vol. 137, No. 17, 28.04.1996, p. 905-911.

Research output: Contribution to journalArticle

@article{c24978c5d56d49f8af97dbdd3804aba7,
title = "Malignus pajzsmirigytumorok Magyarorsz{\'a}gon: morbidit{\'a}s {\'e}s mortalit{\'a}s.",
abstract = "In 1993, 181 new cases (36 men and 145 women) of thyroid cancer were diagnosed pathologically in Hungary, i.e. a morbidity of 1.8/100,000 for the total population, and of 0.7/100,000 and 2.7/100,000 for men and women, respectively. The distribution of the histological diagnoses: 61{\%} papillary, 25{\%} follicular, 5{\%} medullary and 3{\%} anaplastic carcinomas, and 6{\%} others. In the same year, 125 patients (31 men and 94 women) died from thyroid cancer, i.e. a mortality rate of 1.2/100,000 for the total population, and of 0.6/100,000 and 1.8/100,000 for men and women, respectively. The relatively low morbidity reflects the fact that no new strong aetiological factor is operative in Hungary. The substantial mortality rate, however, is influenced by the geographically determined aggressivity of the disease, the inadequacy of the diagnostic procedures and therapeutic measures, and lack of the active follow-up. The latter facts are especially prominent in centres with a low patient turnover. In the field of health care, various measures must be introduced to prevent an increase in the morbidity and to diminish the mortality. Reduction of the iodine deficiency, rationalization of the medical use of ionizing irradiation, and implementation of the necessary hormonal medication for all patients operated by resection for thyroid diseases are needed for tumour prophylaxis. Before any medical decision-making, the achievement of complete diagnostic information, including the pathological revision of clinically questionable cases, is of paramount importance. The fundamental goals as concerns the treatment modalities are as follows: increased surgical skill and level of performance of external irradiation, the availability of radionuclide therapy, and guidance of all types of thyroxine medication by endocrine experts.",
author = "O. {\'E}sik and Z. Szentirmay and G. Tusn{\'a}dy and G. N{\'e}meth and M. K{\'a}sler",
year = "1996",
month = "4",
day = "28",
language = "Hungarian",
volume = "137",
pages = "905--911",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "17",

}

TY - JOUR

T1 - Malignus pajzsmirigytumorok Magyarországon

T2 - morbiditás és mortalitás.

AU - Ésik, O.

AU - Szentirmay, Z.

AU - Tusnády, G.

AU - Németh, G.

AU - Kásler, M.

PY - 1996/4/28

Y1 - 1996/4/28

N2 - In 1993, 181 new cases (36 men and 145 women) of thyroid cancer were diagnosed pathologically in Hungary, i.e. a morbidity of 1.8/100,000 for the total population, and of 0.7/100,000 and 2.7/100,000 for men and women, respectively. The distribution of the histological diagnoses: 61% papillary, 25% follicular, 5% medullary and 3% anaplastic carcinomas, and 6% others. In the same year, 125 patients (31 men and 94 women) died from thyroid cancer, i.e. a mortality rate of 1.2/100,000 for the total population, and of 0.6/100,000 and 1.8/100,000 for men and women, respectively. The relatively low morbidity reflects the fact that no new strong aetiological factor is operative in Hungary. The substantial mortality rate, however, is influenced by the geographically determined aggressivity of the disease, the inadequacy of the diagnostic procedures and therapeutic measures, and lack of the active follow-up. The latter facts are especially prominent in centres with a low patient turnover. In the field of health care, various measures must be introduced to prevent an increase in the morbidity and to diminish the mortality. Reduction of the iodine deficiency, rationalization of the medical use of ionizing irradiation, and implementation of the necessary hormonal medication for all patients operated by resection for thyroid diseases are needed for tumour prophylaxis. Before any medical decision-making, the achievement of complete diagnostic information, including the pathological revision of clinically questionable cases, is of paramount importance. The fundamental goals as concerns the treatment modalities are as follows: increased surgical skill and level of performance of external irradiation, the availability of radionuclide therapy, and guidance of all types of thyroxine medication by endocrine experts.

AB - In 1993, 181 new cases (36 men and 145 women) of thyroid cancer were diagnosed pathologically in Hungary, i.e. a morbidity of 1.8/100,000 for the total population, and of 0.7/100,000 and 2.7/100,000 for men and women, respectively. The distribution of the histological diagnoses: 61% papillary, 25% follicular, 5% medullary and 3% anaplastic carcinomas, and 6% others. In the same year, 125 patients (31 men and 94 women) died from thyroid cancer, i.e. a mortality rate of 1.2/100,000 for the total population, and of 0.6/100,000 and 1.8/100,000 for men and women, respectively. The relatively low morbidity reflects the fact that no new strong aetiological factor is operative in Hungary. The substantial mortality rate, however, is influenced by the geographically determined aggressivity of the disease, the inadequacy of the diagnostic procedures and therapeutic measures, and lack of the active follow-up. The latter facts are especially prominent in centres with a low patient turnover. In the field of health care, various measures must be introduced to prevent an increase in the morbidity and to diminish the mortality. Reduction of the iodine deficiency, rationalization of the medical use of ionizing irradiation, and implementation of the necessary hormonal medication for all patients operated by resection for thyroid diseases are needed for tumour prophylaxis. Before any medical decision-making, the achievement of complete diagnostic information, including the pathological revision of clinically questionable cases, is of paramount importance. The fundamental goals as concerns the treatment modalities are as follows: increased surgical skill and level of performance of external irradiation, the availability of radionuclide therapy, and guidance of all types of thyroxine medication by endocrine experts.

UR - http://www.scopus.com/inward/record.url?scp=18544392901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544392901&partnerID=8YFLogxK

M3 - Article

C2 - 8649753

AN - SCOPUS:18544392901

VL - 137

SP - 905

EP - 911

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 17

ER -